Lv31
340 积分 2025-04-09 加入
Targeting immune cell recruitment in atherosclerosis
2小时前
待确认
Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis
4天前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
12天前
已完结
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option
3个月前
已完结
Adrenal insufficiency: identification and management—summary of new NICE guidance
3个月前
已完结
Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center
3个月前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
3个月前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
3个月前
已完结
Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta-Analysis and Systematic Review
3个月前
已完结
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact
5个月前
已完结
皖公网安备34019202002308
